David Eichenbaum

2.2k total citations · 1 hit paper
45 papers, 643 citations indexed

About

David Eichenbaum is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, David Eichenbaum has authored 45 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Ophthalmology, 22 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Molecular Biology. Recurrent topics in David Eichenbaum's work include Retinal Diseases and Treatments (32 papers), Retinal and Optic Conditions (21 papers) and Retinal Imaging and Analysis (20 papers). David Eichenbaum is often cited by papers focused on Retinal Diseases and Treatments (32 papers), Retinal and Optic Conditions (21 papers) and Retinal Imaging and Analysis (20 papers). David Eichenbaum collaborates with scholars based in United States, Switzerland and United Kingdom. David Eichenbaum's co-authors include Charles C. Wykoff, Arshad M. Khanani, Seenu M. Hariprasad, Thomas A. Ciulla, Daniel B. Roth, David R. Lally, Lauren Hill, Anne E. Fung, Zdenka Hašková and Jeffrey S. Heier and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

David Eichenbaum

41 papers receiving 630 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

2023 82 citations Sunil Patel, David R. Lally et al. Eye profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Eichenbaum United States	15	568	431	129	36	27	45	643
Jans Fromow-Guerra Mexico	15	799 1.4×	617 1.4×	101 0.8×	13 0.4×	37 1.4×	52	880
Liran Tiosano Israel	14	491 0.9×	312 0.7×	126 1.0×	28 0.8×	7 0.3×	36	568
Kourous A. Rezaei United States	7	338 0.6×	220 0.5×	140 1.1×	55 1.5×	17 0.6×	22	429
Swaantje Grisanti Germany	10	336 0.6×	243 0.6×	83 0.6×	23 0.6×	13 0.5×	17	392
João Paulo Castro Sousa Portugal	15	406 0.7×	270 0.6×	100 0.8×	16 0.4×	38 1.4×	44	510
M Gavin United Kingdom	9	385 0.7×	275 0.6×	69 0.5×	22 0.6×	35 1.3×	10	458
Sara Brandi Bloch Denmark	6	518 0.9×	427 1.0×	76 0.6×	14 0.4×	39 1.4×	9	558
Mark R. Wieland United States	12	972 1.7×	770 1.8×	155 1.2×	24 0.7×	19 0.7×	24	1.1k
Sara Vaz-Pereira Portugal	13	382 0.7×	280 0.6×	72 0.6×	12 0.3×	16 0.6×	33	443
Jason L. Chien United States	12	380 0.7×	178 0.4×	43 0.3×	19 0.5×	55 2.0×	23	455

Countries citing papers authored by David Eichenbaum

Since Specialization

Citations

This map shows the geographic impact of David Eichenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Eichenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Eichenbaum more than expected).

Fields of papers citing papers by David Eichenbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Eichenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Eichenbaum. The network helps show where David Eichenbaum may publish in the future.

Co-authorship network of co-authors of David Eichenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of David Eichenbaum. A scholar is included among the top collaborators of David Eichenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Eichenbaum. David Eichenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hahn, Paul, David Eichenbaum, Dilsher S. Dhoot, et al.. (2025). Efficacy of Intravitreal Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy. Journal of VitreoRetinal Diseases. 10(1). 46–56.

Eichenbaum, David, Arshad M. Khanani, Dante J. Pieramici, et al.. (2025). Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration. American Journal of Ophthalmology. 275. 14–26.

Campochiaro, Peter A., David Eichenbaum, Margaret Chang, et al.. (2024). Interim Results of the Phase III Portal Extension Trial of the Port Delivery System with Ranibizumab in Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 9(2). 144–155. 2 indexed citations

Danzig, Carl J., David Eichenbaum, Amy Ewald, et al.. (2024). Screen Failures in Clinical Trials in Retina. Ophthalmology Retina. 8(11). 1093–1099. 1 indexed citations

Eichenbaum, David, William R. Freeman, Margaret Chang, et al.. (2024). Endophthalmitis in Eyes Treated with the Port Delivery System with Ranibizumab. Ophthalmology Retina. 9(2). 127–143. 2 indexed citations

Pal, Rishi, Thomas A. Albini, Caroline R. Baumal, et al.. (2024). Development of a Consensus Guideline for the Diagnosis and Management of Chronic Noninfectious Uveitis Affecting the Posterior Segment. Ophthalmic surgery, lasers & imaging retina. 55(11). 652–658.

Patel, Sunil, Philip Storey, Mark Barakat, et al.. (2024). Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular Degeneration. Ophthalmology Science. 4(5). 100527–100527. 6 indexed citations

Leitch, Ian M., Michael Gerometta, David Eichenbaum, et al.. (2024). Vascular Endothelial Growth Factor C and D Signaling Pathways as Potential Targets for the Treatment of Neovascular Age-Related Macular Degeneration: A Narrative Review. Ophthalmology and Therapy. 13(7). 1857–1875. 8 indexed citations

Eichenbaum, David, et al.. (2023). Biosimilars in the Treatment of Retinal Disease in the United States. Ophthalmic surgery, lasers & imaging retina. 54(6). 362–366. 1 indexed citations

10.

Callanan, David, Rahul N. Khurana, Raj K. Maturi, et al.. (2023). Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results. Clinical ophthalmology. Volume 17. 1367–1384. 6 indexed citations

11.

Patel, Sunil, David R. Lally, Jason Hsu, et al.. (2023). Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial. Eye. 37(17). 3551–3557. 82 indexed citations breakdown →

12.

Ho, Allen C., Jeffrey S. Heier, Nancy M. Holekamp, et al.. (2021). Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration. Journal of Clinical Medicine. 10(7). 1355–1355. 17 indexed citations

13.

Singer, Michael, Rishi P. Singh, Andrea Gibson, et al.. (2021). Association of Early Anatomic Response with Visual Function in Neovascular Age-Related Macular Degeneration. Ophthalmology. 128(11). 1657–1660. 3 indexed citations

14.

Aziz, Aamir, Arshad M. Khanani, Nikolas London, et al.. (2021). Real World Efficacy and Safety of Brolucizumab in Neovascular AMD: The REBEL Study. Investigative Ophthalmology & Visual Science. 62(8). 451–451. 8 indexed citations

15.

Wykoff, Charles C., Vrinda Hershberger, David Eichenbaum, et al.. (2021). Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results. American Journal of Ophthalmology. 235. 131–142. 20 indexed citations

16.

Khanani, Arshad M., Matthew W. Russell, Aamir Aziz, et al.. (2021). Angiopoietins as Potential Targets in Management of Retinal Disease. Clinical ophthalmology. Volume 15. 3747–3755. 33 indexed citations

17.

Mansour, Sam E., Daniel F. Kiernan, Daniel B. Roth, et al.. (2020). Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study. British Journal of Ophthalmology. 105(3). 414–419. 23 indexed citations

18.

Eichenbaum, David. (2019). Association Between Early Vision-Related Quality of Life Outcomes and Anatomic Dryness Response in Neovascular Age-Related Macular Degeneration (nAMD): A Post-Hoc Analysis of VIEW Trials. Investigative Ophthalmology & Visual Science. 60(9). 90–90. 1 indexed citations

19.

Wykoff, Charles C., David Eichenbaum, Daniel B. Roth, et al.. (2018). Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy. Ophthalmology Retina. 2(10). 997–1009. 69 indexed citations

20.

Liu, Mimi, et al.. (2017). Branch and central retinal vein occlusion: clinical pearls from trials of ranibizumab. Investigative Ophthalmology & Visual Science. 58(8). 4624–4624. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact